Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
LEBER'S DISEASE WITH SYMPTOMS RESEMBLING DISSEMINATED SCLEROSIS.
CUPID: Cannabinoid Use in Progressive Inflammatory brain Disease
The prevalence of multiple sclerosis in the city of Santos has remained unaltered for five years.
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis.
Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.
Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis.
Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
Fingolimod-associated amenorrhea: a report of three cases.
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.
Treatment Update in Multiple Sclerosis.
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis.
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum.
Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
[Spasticity and everyday life in multiple sclerosis].
Persons with multiple sclerosis show altered joint kinetics during walking after participating in elliptical exercise.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Pages
« first
‹ previous
…
279
280
281
282
283
284
285
286
287
…
next ›
last »